Interethnic variation of CYP2C19 alleles, ‘predicted’ phenotypes and ‘measured’ metabolic phenotypes across world populations
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Interethnic variation of CYP2C19 alleles, ‘predicted’ phenotypes and ‘measured’ metabolic phenotypes across world populations
Authors
Keywords
-
Journal
PHARMACOGENOMICS JOURNAL
Volume 16, Issue 2, Pages 113-123
Publisher
Springer Nature
Online
2015-10-27
DOI
10.1038/tpj.2015.70
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- CYP2C19*17 affects R-warfarin plasma clearance and warfarin INR/dose ratio in patients on stable warfarin maintenance therapy
- (2015) Ming Chang et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Prevalence and significance ofCYP2C19*2andCYP2C19*17alleles in a New Zealand acute coronary syndrome population
- (2015) P. D. Larsen et al. INTERNAL MEDICINE JOURNAL
- The Hawaii clopidogrel lawsuit: the possible effect on clinical laboratory testing
- (2015) Alan HB Wu et al. Personalized Medicine
- Inactive alleles of cytochrome P450 2C19 may be positively selected in human evolution
- (2014) Ramatoulie E Janha et al. BMC EVOLUTIONARY BIOLOGY
- Clinical Pharmacogenetics Implementation Consortium Guidelines for Cytochrome P450 2D6 Genotype and Codeine Therapy: 2014 Update
- (2014) K R Crews et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Frequency distribution of high risk alleles of CYP2C19, CYP2E1, CYP3A4 genes in Haryana population
- (2014) Sachin Gulati et al. ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY
- Interethnic variability ofCYP2D6alleles and of predicted and measured metabolic phenotypes across world populations
- (2014) Adrián LLerena et al. Expert Opinion on Drug Metabolism & Toxicology
- Genetic polymorphisms of CYP2C8, CYP2C9 and CYP2C19 in Ecuadorian Mestizo and Spaniard populations: a comparative study
- (2014) Jorge Vicente et al. MOLECULAR BIOLOGY REPORTS
- Distribution of ABCB1, CYP3A5, CYP2C19, and P2RY12 gene polymorphisms in a Mexican Mestizos population
- (2014) Gilberto Vargas-Alarcón et al. MOLECULAR BIOLOGY REPORTS
- Characterization of CYP1A2, CYP2C19, CYP3A4 and CYP3A5 polymorphisms in South Brazilians
- (2014) Fabiana B. Kohlrausch et al. MOLECULAR BIOLOGY REPORTS
- Evaluation of the relationship between polymorphisms inCYP2C19and the pharmacokinetics of omeprazole, pantoprazole and rabeprazole
- (2014) Manuel Román et al. PHARMACOGENOMICS
- A combined high CYP2D6-CYP2C19 metabolic capacity is associated with the severity of suicide attempt as measured by objective circumstances
- (2014) E Peñas-Lledó et al. PHARMACOGENOMICS JOURNAL
- A rapid and simple LC–MS/MS method for the simultaneous evaluation of CYP1A2, CYP2C9, CYP2C19, CYP2D6 and CYP3A4 hydroxylation capacity
- (2014) Fernando de Andrés et al. Bioanalysis
- Hydroxylation index of omeprazole in relation to CYP2C19 polymorphism and sex in a healthy Iranian population
- (2014) Maryam Payan et al. DARU-Journal of Pharmaceutical Sciences
- CYP2C19Genetic Polymorphism in Saudi Arabians
- (2013) Fahad I. Al-Jenoobi et al. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY
- Introduction of the AmpliChip CYP450 Test to a South African cohort: a platform comparative prospective cohort study
- (2013) Tyren M Dodgen et al. BMC Medical Genetics
- Newly identified synergy between clopidogrel and calcium-channel blockers for blood pressure regulation possibly involves CYP2C19 rs4244285
- (2013) Maria G. Stathopoulou et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Genotype-Phenotype Analysis of CYP2C19 in Healthy Saudi Individuals and its Potential Clinical Implication in Drug Therapy
- (2013) Leena H Saeed et al. International Journal of Medical Sciences
- High prevalence of CYP2C19*2 allele in Roma samples: study on Roma and Hungarian population samples with review of the literature
- (2013) Csilla Sipeky et al. MOLECULAR BIOLOGY REPORTS
- Decreased hippocampal volume and increased anxiety in a transgenic mouse model expressing the human CYP2C19 gene
- (2013) A Persson et al. MOLECULAR PSYCHIATRY
- A Systematically Combined Genotype and Functional Combination Analysis of CYP2E1, CYP2D6, CYP2C9, CYP2C19 in Different Geographic Areas of Mainland China – A Basis for Personalized Therapy
- (2013) Zhenqiang Wu et al. PLoS One
- Distribution ofCYP2C19*2andCYP2C19*3polymorphisms in Venezuelan populations with different admixture
- (2012) Dinorah Castro de Guerra et al. ANNALS OF HUMAN BIOLOGY
- Allele and Genotype Frequencies of CYP3A4, CYP2C19, and CYP2D6 in Han, Uighur, Hui, and Mongolian Chinese Populations
- (2012) Liang Jin Zuo et al. Genetic Testing and Molecular Biomarkers
- Distribution of CYP2D6 and CYP2C19 Polymorphisms Associated with Poor Metabolizer Phenotype in Five Amerindian Groups and Western Mestizos from Mexico
- (2012) Joel Salazar-Flores et al. Genetic Testing and Molecular Biomarkers
- Allele and Genotype Frequencies of CYP2B6 and CYP2C19 Polymorphisms in Egyptian Agricultural Workers
- (2012) Corie A. Ellison et al. JOURNAL OF TOXICOLOGY AND ENVIRONMENTAL HEALTH-PART A-CURRENT ISSUES
- Allele and genotype frequencies of the polymorphic cytochrome P450 genes (CYP1A1, CYP3A4, CYP3A5, CYP2C9 and CYP2C19) in the Jordanian population
- (2012) Al-Motassem Yousef et al. MOLECULAR BIOLOGY REPORTS
- Genetic polymorphisms and novel allelic variants of CYP2C19 in the Chinese Han population
- (2012) Li-Ming Hu et al. PHARMACOGENOMICS
- Neurological toxicity after phenytoin infusion in a pediatric patient with epilepsy: influence of CYP2C9, CYP2C19 and ABCB1 genetic polymorphisms
- (2012) P Dorado et al. PHARMACOGENOMICS JOURNAL
- Pharmacogenomics of drug-metabolizing enzymes: a recent update on clinical implications and endogenous effects
- (2012) S C Sim et al. PHARMACOGENOMICS JOURNAL
- The great human expansion
- (2012) B. M. Henn et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Frequencies of 23 Functionally Significant Variant Alleles Related with Metabolism of Antineoplastic Drugs in the Chilean Population: Comparison with Caucasian and Asian Populations
- (2012) Ángela Roco et al. Frontiers in Genetics
- Distribution of CYP2C Polymorphisms in an Amerindian Population of Brazil
- (2011) Daniela D. Vargens et al. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY
- CYP2C19 and ABCB1gene polymorphisms are differently distributed according to ethnicity in the Brazilian general population
- (2011) Paulo CJL Santos et al. BMC Medical Genetics
- Pilot study for the characterization of pharmacogenetically relevant CYP2D6, CYP2C19 and ABCB1 gene polymorphisms in the Hungarian population
- (2011) Orsolya Rideg et al. CELL BIOCHEMISTRY AND FUNCTION
- Population Differences in Major Functional Polymorphisms of Pharmacokinetics/pharmacodynamics-related Genes in Eastern Asians and Europeans: Implications in the Clinical Trials for Novel Drug Development
- (2011) Kouichi Kurose et al. Drug Metabolism and Pharmacokinetics
- Distribution of CYP2C19*17 allele and genotypes in an Indian population
- (2011) D. Anichavezhi et al. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS
- Differences in genotype and allele frequency distributions of polymorphic drug metabolizing enzymes CYP2C19 and CYP2D6 in mainland Chinese Mongolian, Hui and Han populations
- (2011) S.-J. Yin et al. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS
- Prevalence of CYP2C19 polymorphisms in the Lebanese population
- (2011) Isabelle Djaffar Jureidini et al. MOLECULAR BIOLOGY REPORTS
- Genetic polymorphism of CYP2C19 in a Jordanian population: influence of allele frequencies of CYP2C19*1 and CYP2C19*2 on the pharmacokinetic profile of lansoprazole
- (2011) Imad Zalloum et al. MOLECULAR BIOLOGY REPORTS
- Genetic variants inCYP(-1A2,-2C9,-2C19,-3A4and-3A5),VKORC1andABCB1genes in a black South African population: a window into diversity
- (2011) Collet Dandara et al. PHARMACOGENOMICS
- CYP2C19 activity comparison between Swedes and Koreans: effect of genotype, sex, oral contraceptive use, and smoking
- (2010) Margareta Ramsjö et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Linkage disequilibrium between the CYP2C19*17 allele and wildtype CYP2C8 and CYP2C9 alleles: identification of CYP2C haplotypes in healthy Nordic populations
- (2010) Rasmus S. Pedersen et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Analysis of 50 SNPs in CYP2D6, CYP2C19, CYP2C9, CYP3A4 and CYP1A2 by MALDI-TOF mass spectrometry in Chinese Han population
- (2010) Yan Shi et al. FORENSIC SCIENCE INTERNATIONAL
- Microarray-Based Detection of CYP1A1, CYP2C9, CYP2C19, CYP2D6, GSTT1, GSTM1, MTHFR, MTRR, NQO1, NAT2, HLA-DQA1, and AB0 Allele Frequencies in Native Russians
- (2010) Olga Gra et al. Genetic Testing and Molecular Biomarkers
- Genetic polymorphisms of cytochrome P450 enzymes 2C9 and 2C19 in a healthy Mongolian population in China
- (2010) Z.F. Yang et al. GENETICS AND MOLECULAR RESEARCH
- Characterization of the genetic profile ofCYP2C19in two South African populations
- (2010) Britt I Drögemöller et al. PHARMACOGENOMICS
- Global pharmacogenomics: Impact of population diversity on the distribution of polymorphisms in the CYP2C cluster among Brazilians
- (2010) G Suarez-Kurtz et al. PHARMACOGENOMICS JOURNAL
- Characterisation of CYP2C8, CYP2C9 and CYP2C19 polymorphisms in a Ghanaian population
- (2009) William Kudzi et al. BMC Medical Genetics
- Identification of New CYP2C19 Variants Exhibiting Decreased Enzyme Activity in the Metabolism of S-Mephenytoin and Omeprazole
- (2009) S.-J. Lee et al. DRUG METABOLISM AND DISPOSITION
- Genetic Variations and Haplotypes of the 5´ Regulatory Region of CYP2C19 in South Indian Population
- (2009) Chakradhara Rao Uppugunduri Satyanarayana et al. Drug Metabolism and Pharmacokinetics
- CYP2C19haplotypes in Koreans as a marker of enzyme activity evaluated with omeprazole
- (2009) S. K. Jin et al. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS
- Assessment of CYP2C19 genetic polymorphisms in a korean population using a simultaneous multiplex pyrosequencing method to simultaneously detect the CYP2C19*2, CYP2C19*3, and CYP2C19*17 alleles
- (2009) K.-A. Kim et al. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS
- Pharmacogenetic variation at CYP2C9, CYP2C19, and CYP2D6 at global and microgeographic scales
- (2009) Johanna Sistonen et al. Pharmacogenetics and Genomics
- Genetic polymorphism, linkage disequilibrium, haplotype structure and novel allele analysis of CYP2C19 and CYP2D6 in Han Chinese
- (2009) Q Zhou et al. PHARMACOGENOMICS JOURNAL
- Limited frequency of the CYP2C19*17 allele and its minor role in a Japanese population
- (2008) Katsuyoshi Sugimoto et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Pharmacokinetics/Genotype Associations for Major Cytochrome P450 Enzymes in Native and First- and Third-generation Japanese Populations: Comparison With Korean, Chinese, and Caucasian Populations
- (2008) SP Myrand et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Cytochrome P450 2C19 genetic polymorphisms in Ugandans
- (2008) Jun Miura et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Pharmacogenomics of CYP2A6, CYP2B6, CYP2C19, CYP2D6, CYP3A4, CYP3A5 and MDR1 in Vietnam
- (2008) M. I. Veiga et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Global pharmacogenetics: genetic substructure of Eurasian populations and its effect on variants of drug-metabolizing enzymes
- (2008) Oksana Makeeva et al. PHARMACOGENOMICS
- Genetic polymorphism analysis ofCYP2C19in Chinese Han populations from different geographic areas of mainland China
- (2008) Lingling Chen et al. PHARMACOGENOMICS
- Reliability of the omeprazole hydroxylation index for CYP2C19 phenotyping: possible effect of age, liver disease and length of therapy
- (2003) Miyuki Kimura et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More